TLR4 and cancer: In contrast, HMGB1 release from dying cancer cells can activate anticancer immunity: the complex of HMGB1 with RAGE or Toll-like receptor 4 (TLR4) triggers cascades of reaction that lead to the local secretion of proinflammatory cytokines, including IL−1, IL−6 and TNF-α [34].